Enabling Powerful POC and Mobile Diagnostics
There is a significant need for highly sensitive mobile diagnostics that can be performed closer to the patient at point of care, e.g., decentralized diagnostics. To meet this need, LamdaGen has developed a category-defining digital diagnostic platform that enables significant performance advantages over central laboratory testing relative to speed, high sensitivity, precise quantitation and importantly – mobility.
LamdaGen’s L’AuRa technology enables powerful adaptive mobile diagnostic systems that are simple, compact and cost effective. L’AuRa’s game-changing diagnostic platform provides our partners with robust testing systems that offer:
- Competitive advantages
- Deeper market penetration and new market entry
- Accelerated growth
L’AuRa couples its proprietary digital detection with its nano-based biosensors to enable diagnostics systems with high sensitivity, precise quantitation and rapid performance in truly mobile or POC formats.
Chart above illustrates L’AuRa’s diagnostic performance in terms of time and sensitivity as compared to ELISA and Lateral Flow
Introducing L’AuRa:
Read More ›
Saliva-based Cortisol Assay:
Read More ›
Troponin I (cTnI) Ap Note:
Read More ›
LamdGen’s Micro-8 nano-based biosensors for multiplexed targets
L’AuRa Digital Diagnostics
The L’AuRa diagnostic system is ideal for enabling high sensitivity, quantitative POC, mobile rapid testing.
LightPath™ S4
LamdaGen’s LightPath S4 system performs highly sensitive label-free, real-time monitoring and characterization of biomolecular interactions.
LSPR Biosensors
LamdaGen’s metallic thin-film LSPR-based Optical Biosensors for research and development in the areas of Life Science and Cleantech.